Jobs
-
According to Swedish device developer Iconovo, the company has raised $1 million in venture capital that it will use for development of dry powder inhalation devices. The company also said that Lennart Holm, chairman of… Read more . . .
-
FSC Laboratories has announced that its Flexichamber collapsible valved holding chamber has received FDA clearance for use with most pMDIs. The device, which can be used with or without a mask, will be available by… Read more . . .
-
Results from a 24-week study comparing GSK’s Anoro Ellipta umeclidinium /vilanterol DPI to Boehringer Ingelheim’s Spiriva Handihaler tiotropium DPI published in Respiratory Medicine show statistically greater improvement in trough FEV1 and weighted mean FEV1 0… Read more . . .
-
Retrophin has announced that Turing Pharmaceuticals will pay $3 million up front for three of Retrophin’s products, including Syntocinon oxytocin nasal spray and ketamine. According to the company, the agreement includes the resignation of Retrophin… Read more . . .
-
Novel Laboratories, Inc. is a fast growing specialty pharmaceutical products development and manufacturing company located in New Jersey. We are looking for experienced, senior level scientists/formulators/engineers for the development of Metered Dose Inhalers, Nasal Sprays… Read more . . .
-
Swedish CRO Inhalation Sciences AB (ISAB) has announced the hires of Mikael Mikko as a product specialist and Iwona Rådberg as an ex vivo and in vivo studies specialist. Mikko, who has a doctorate in… Read more . . .
-
Aptuit has named Manuela Leone as Executive VP, Operations and General Manager of the Aptuit Center for Drug Discovery & Development in Verona, Italy, where the company provides inhaled drug development and clinical supply manufacturing… Read more . . .
-
California-based biopharmaceutical company OrPro Therapeutics says that pre-clinical studies of its lead compound, ORP-100, an inhaled thioredoxin, has shown that ORP-100 reduces the viscosity and adhesiveness of the sputum of cystic fibrosis patients both in… Read more . . .
-
The Portuguese Health Authority (Infarmed) has approved Sandoz’s AirFluSal Forspiro salmeterol/fluticasone DPI for the treatment of asthma and COPD, triggering a €1.5 million milestone payment to developer Vectura. Sandoz licensed AirFluSal Forspiro from Vectura in… Read more . . .
-
Boehringer Ingelheim has announced that the Striverdi Respimat olodaterol soft mist inhaler is now available in the United States. The FDA approved Striverdi Respimat for the treatment of COPD in July 2014. The company said… Read more . . .
Featured event:
Upcoming Events
Sponsored by Intertek,, hosts of
The Inhaled & Nasal Biologics | DNA Forum
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
October 21-October 22: MVIC Symposium, Lund, Sweden
October 28-October 30: Deutches Aerosol Therapie Symposium (DATS), Marburg, Germany
November 10-November 11: Rescon Europe 2026, Porto, Portugal
December 9-December 11: DDL 2026, Edinburgh, Scotland